Skip to main content
Premium Trial:

Request an Annual Quote

Under Pressure

A lack of support for early- and even mid-career scientists came up at the New Zealand Association of Scientists meeting held in Wellington this week. At his blog, Peter Griffin outlines some of the meeting's talking points related to issues faced by up-and-coming scientists and their employers. Overall, Griffin says, "there was a lot of discussion … about the pressure on emerging scientists to be masters of all trades — not just good at science, but savvy at communicating their science as well as networking and understanding the needs of the business community." Funding is tight, competition is fierce, and "the momentum is swinging towards commercialization and applied science," Griffin says. Despite those challenges, "emerging researchers most definitely do have a future in New Zealand and the more engaged they are in the issues and in articulating the value of their science, the more likely they are to see change that will help secure their futures here," he adds.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.